Total Funding
53
38
Total FundingPost-IPO Equity raised
Growth Score
-30 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
132746
Vivoryon is a clinical stage company focused on bringing first-in-class therapies to patients suffering from age-related diseases.
Konrad Glund: Co-FounderPast Role: Martin Luther University of Halle-Wittenberg, Academic Lecturer and Team Leader
Hendrik Liebers: CFO
About the Company
Vivoryon Therapeutics is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.
